Therapeutic index improvement of antibody-drug conjugates

Hans-Peter Gerbera Department of Research and Development, Codeable Therapeutics, Palo Alto, CA, USACorrespondence[email protected]
View further author information

Sanjeev Gangwara Department of Research and Development, Codeable Therapeutics, Palo Alto, CA, USAView further author information

Alison Bettsb Department of DMPK & Modeling, Applied BioMath, Concord, MA, USA;c Department of DMPK & Modeling, Preclinical & Translational Sciences, Takeda Pharmaceutical Company Limited, Cambridge, MA, USAView further author information

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qihong Huang, Minu Ravindra Pilvankar, Rakesh Dixit & Hongbin Yu. Approaches to Improve the Translation of Safety, Pharmacokinetics and Therapeutic Index of ADCs. Xenobiotica 0:0, pages 1-16.
Read now

Articles from other publishers (2)

Prazwala Chirravur. (2024) Unsung oral toxicities of antibody drug conjugate. Oral Oncology 150, pages 106692.
Crossref

Alfonso López de Sá, Cristina Díaz-Tejeiro, Elisa Poyatos-Racionero, Cristina Nieto-Jiménez, Lucía Paniagua-Herranz, Adrián Sanvicente, Emiliano Calvo, Pedro Pérez-Segura, Víctor Moreno, Francisco Moris & Alberto Ocana. (2023) Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned. Journal of Hematology & Oncology 16:1.
Crossref

Therapeutic index improvement of antibody-drug conjugates

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Therapeutic index improvement of antibody-drug conjugates

Citations (3)

Read on this site (1)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date